These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 2192063

  • 21. Back mutations to the TEM-1 beta-lactamase from TRC-1 lead to restored sensitivity to clavulanic acid.
    Thomson CJ, Amyes SG.
    J Med Microbiol; 1995 Jun; 42(6):429-32. PubMed ID: 7791208
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A new TEM-derived extended-spectrum beta-lactamase (TEM-91) with an R164C substitution at the omega-loop confers ceftazidime resistance.
    Kurokawa H, Shibata N, Doi Y, Shibayama K, Kamachi K, Yagi T, Arakawa Y.
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2981-3. PubMed ID: 12937007
    [Abstract] [Full Text] [Related]

  • 29. Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.
    Rice LB, Carias LL, Bonomo RA, Shlaes DM.
    J Infect Dis; 1996 Jan; 173(1):151-8. PubMed ID: 8537652
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A novel chromosomal TEM derivative and alterations in outer membrane proteins together mediate selective ceftazidime resistance in Escherichia coli.
    Weber DA, Sanders CC, Bakken JS, Quinn JP.
    J Infect Dis; 1990 Aug; 162(2):460-5. PubMed ID: 2197339
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. TLA-1: a new plasmid-mediated extended-spectrum beta-lactamase from Escherichia coli.
    Silva J, Aguilar C, Ayala G, Estrada MA, Garza-Ramos U, Lara-Lemus R, Ledezma L.
    Antimicrob Agents Chemother; 2000 Apr; 44(4):997-1003. PubMed ID: 10722503
    [Abstract] [Full Text] [Related]

  • 36. [A plasmid-mediated SHV type extended-spectrum beta-lactamase in Beijing isolate of Enterobacter gergoviae].
    Cheng Y, Li Y, Chen M.
    Wei Sheng Wu Xue Bao; 1994 Apr; 34(2):106-12. PubMed ID: 8073758
    [Abstract] [Full Text] [Related]

  • 37. Extended spectrum beta-lactamase from Klebsiella oxytoca, not belonging to the TEM or SHV family.
    Wu SW, Dornbusch K, Norgren M, Kronvall G.
    J Antimicrob Chemother; 1992 Jul; 30(1):3-16. PubMed ID: 1429334
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. TEM-71, a novel plasmid-encoded, extended-spectrum beta-lactamase produced by a clinical isolate of Klebsiella pneumoniae.
    Rasheed JK, Anderson GJ, Queenan AM, Biddle JW, Oliver A, Jacoby GA, Bush K, Tenover FC.
    Antimicrob Agents Chemother; 2002 Jun; 46(6):2000-3. PubMed ID: 12019125
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.